Delivery Order SPE2DB22D9353-SPE2DB25FX1TW

Award Date 3/25/25
Potential Completion Date 4/15/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,780.55 contract is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $49,795.52, is for the delivery of VABYSMO 6 mg/0.05 mL vial 0.05 mL to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $58,336.00, is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $48,013.50, is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a prescription pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to DMS Pharmaceutical Group by the DLA under the SPE2DB program, which has a...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $46,683.30 award is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, to fulfill the recurring medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with a ceiling value of $4,375.20 and a period of performance through March 12, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
The U.S. government agency Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,673.32 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, under the SPE2DB indefinite delivery contract (IDC) valued up to $499,999,999, is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML medication to support the recurring pharmaceutical needs of Department of Defense (DoD) healthcare facilities worldwide. This...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the SPE2DX24F5ZTH contract vehicle to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $31,122.20 order is for the provision of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $7,292 contract is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product, with a performance period ending on February 14, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $46,683.30, is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery...
  • SPE2DB22D9353
    Indefinite Delivery Contract
  • SPE2DB22D9353-SPE2DB25FX1TW
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $14,584.00 and covers the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. This contract is not associated with any set-aside designation.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of Department of Defense healthcare sites worldwide.

Generated 6/24/25, 9:56 AM